Chlorproguanil-dapsone (LAPDAP) for uncomplicated falciparum malaria. - Wikidata - awgldk - TriplyDB

Chlorproguanil-dapsone (LAPDAP) for uncomplicated falciparum malaria.

Chlorproguanil-dapsone (LAPDAP) for uncomplicated falciparum malaria.

http://www.wikidata.org/entity/Q43796087

about

Molecular monitoring of the Leu-164 mutation of dihydrofolate reductase in a highly sulfadoxine/pyrimethamine-resistant area in Africa Drug repurposing and human parasitic protozoan diseases Open-label comparative clinical study of chlorproguanil-dapsone fixed dose combination (Lapdap) alone or with three different doses of artesunate for uncomplicated Plasmodium falciparum malaria Chemotherapeutic hope on the horizon for Plasmodium vivax malaria?Product R&D for neglected diseases. Twenty-seven years of WHO/TDR experiences with public-private partnerships Randomized trial of safety and effectiveness of chlorproguanil-dapsone and lumefantrine-artemether for uncomplicated malaria in children in the Gambia Virtual drug discovery and development for neglected diseases through public-private partnerships.Folate metabolism as a source of molecular targets for antimalarials.Detection of the dihydrofolate reductase-164L mutation in Plasmodium falciparum infections from Malawi by heteroduplex tracking assay.Application of pharmacogenomics to malaria: a holistic approach for successful chemotherapy.In vitro activities of 2,4-diaminoquinazoline and 2,4-diaminopteridine derivatives against Plasmodium falciparum.Relationship between age, molecular markers, and response to sulphadoxine-pyrimethamine treatment in Kampala, Uganda.Roll back of Plasmodium falciparum antifolate resistance by insecticide-treated nets.

P2860

Q24806194-E3A93489-8852-4932-9472-AE91341BE428 Q26999453-9D02B493-A7F0-491B-9D72-84EF029AA0B9 Q28472247-E8C31C7A-F8D0-4849-B2CD-E9687DDF01CC Q34159239-35D4A6DB-B952-4F3D-A3DD-DB846066D98D Q34250696-27576A9F-C0A0-4763-BDF3-C8E1BBD6C620 Q35031434-8E4E163C-384E-4E43-BBAE-71653FAF4908 Q35605447-86C6D293-B1F8-4B83-AF95-9241A74CBAC7 Q36895753-A0EA826A-5F80-48B2-80FA-097A7A27E60D Q37012863-FBC4000D-D9DC-4BD0-A901-714FC1DFB4D8 Q37278622-A595AC7B-5458-40F9-A1DB-A8D3C0BA3373 Q37568971-17B1F50B-6E37-41EB-B9A1-909B6CECC584 Q38882145-12DB380F-334A-4B13-8F4B-050A5C4C2F21 Q43066760-50F65EE6-6540-45FB-AF9D-7061553A99D1

P2860

Chlorproguanil-dapsone (LAPDAP) for uncomplicated falciparum malaria.

http://www.wikidata.org/entity/Q43796087

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh-hant

name

Chlorproguanil-dapsone (LAPDAP) for uncomplicated falciparum malaria.

@en

Chlorproguanil-dapsone

@nl

type

label

Chlorproguanil-dapsone (LAPDAP) for uncomplicated falciparum malaria.

@en

Chlorproguanil-dapsone

@nl

prefLabel

Chlorproguanil-dapsone (LAPDAP) for uncomplicated falciparum malaria.

@en

Chlorproguanil-dapsone

@nl

P1433

Q43796087-1A833FA0-0781-4DC9-B612-A27189D87DB1

P1476

Q43796087-E0EA8F12-BE1A-445F-BCCF-D79FA0FC9154

P2093

Q43796087-A315876A-7C9C-4595-95C7-AED0A6B35CAE

P2860

Q43796087-0C685B36-5D12-42AD-A941-FE49A4D2558E

Q43796087-335C826A-D92F-4ACC-8046-C40D2C3BE9B9

Q43796087-4876D192-6444-41BB-B2ED-EA96446FDDE0

Q43796087-7101BFBD-B151-454E-937B-8E00973E2F20

Q43796087-8109D1B0-139C-46DE-A8E6-8F2DA89D0489

Q43796087-983F7BBA-0F1F-4C0C-8475-B00131DFE42B

Q43796087-D379F577-F2E8-4686-9508-470900ED983E

Q43796087-E5715148-F269-41C0-B448-FFEAB52747A9

Q43796087-F7B36773-DFDC-4171-93FC-C01109AC4A99

P304

Q43796087-2CEA8F33-0063-4441-B6EA-63AFB69DF2D8

P31

Q43796087-49D6DCF9-78BA-4431-ABF1-99B8A76A0246

P356

Q43796087-C2D3F554-F127-4D9C-8C50-5B676E8F7476

P433

Q43796087-192D726F-D27A-46E7-A1C5-4BFEB7AA95DF

P478

Q43796087-E1897A01-8B4C-407C-94D6-6942DFB731B6

P577

Q43796087-D5D6145C-A7DA-40F7-B564-E8F056F662C7

P5875

Q43796087-DEC10A63-C425-4A3F-9E89-0A9CF253E8C9

P698

Q43796087-6959A300-DDB7-48FE-BF0D-0FC56BA907F0

P921

Q43796087-3EA1542D-CBE6-412C-9084-7D249FC9D447

Q43796087-92E61D79-D69A-4561-88FE-B2C593545CAA

P356

J.1365-3156.2001.00751.X

P1433

Tropical Medicine and International Health

P1476

Chlorproguanil-dapsone (LAPDAP) for uncomplicated falciparum malaria.

@en

P2093

Winstanley P

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate Pyrimethamine/Sulfadoxine compared with the shorter-acting chlorproguanil/dapsone on Kenyan Plasmodium falciparum.

Chemotherapy for falciparum malaria: the armoury, the problems and the prospects.

Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasites

Preventing antimalarial drug resistance through combinations.

In vitro activities of novel antifolate drug combinations against Plasmodium falciparum and human granulocyte CFUs.

The efficacy of antifolate antimalarial combinations in Africa: a predictive model based on pharmacodynamic and pharmacokinetic analyses.

Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania.

Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-life.

Chlorproguanil/dapsone for uncomplicated Plasmodium falciparum malaria in young children: pharmacokinetics and therapeutic range.

P304

952-954

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1365-3156.2001.00751.X

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2001-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11650603

http://www.w3.org/2001/XMLSchema#string

P698

11703851

http://www.w3.org/2001/XMLSchema#string

P921

Plasmodium falciparum